Dr Julie-Ann Penton PhD
Head of Pharmaceutical Development
Julie-Ann has over 18 years’ experience in the pharmaceutical industry working in pharmaceutical development and project management roles. She initially entered the pharmaceutical industry as a formulation development scientist for Rhone Poulenc Rorer (now Sanofi Aventis) before moving to Innovata Biomed (now Vectura) where she eventually became Director of Pharmaceutical Development and was responsible for both early phase and late phase pharmaceutical development projects.
Julie-Ann has extensive experience of managing all aspects of pharmaceutical development and has specific expertise in outsourcing and managing these activities at contract organisations. She also has specific expertise in writing and compiling the CMC components of regulatory packages and has significant experience with EU, US, and Japanese programmes. She has also acted as a pharmaceutical expert for a number of EU submissions.
Julie-Ann has also held roles in project management including the role of Projects Director at Vectura where she was responsible for the overall delivery of both early and late phase/commercialisation projects from cross functional project teams.
Julie-Ann has a degree in Pharmacy and holds a PhD in pharmaceutical drug delivery from the University of Manchester.
Since 2014 Julie-Ann has taken on the role of Head of Pharmaceutical Development for Therakind Limited.